Most Popular Stories
- FDA approvals of 2011
- Will $1B cancer IP theft suit trigger tighter vigilance on researchers' work?
- Sanofi chief can't spark much enthusiasm for new MS drugs
- Gloom for the pharma industry, yes. Doom? No
- AstraZeneca's R&D chief in China lays out $100M strategy
- Astellas scores highest in Japanese M&A bout
Free Newsletter
FierceBiomarkers provides biopharma executives and researchers with the latest news and trends on biomarkers. Sign up today to receive your FREE "insiders only" twice-monthly email briefing!
About | View Sample | Privacy
Top Tags
Biography for Liz Jones Hollis
Liz Hollis is the editor-at-large in the Life Sciences group at FierceMarkets. Before joining the company, she was the editor of Generic Line at FDAnews, where she also held the position of eZine editor. She also has worked at the Competitive Enterprise Institute as assistant editorial director. She loves the Chicago Bears, running and dogs. She is based at the FierceMarkets main office in Washington, D.C., and can be reached at ehollis@fiercemarkets.com. Follow @FiercePharma on Twitter and find her on LinkedIn.
Articles by Liz Jones Hollis
- September 20, 2011
- November 30, 2010
- November 17, 2010
- November 2, 2010
- October 19, 2010
- October 6, 2010
- September 22, 2010
- September 8, 2010
- August 24, 2010
- August 11, 2010
- July 28, 2010
- July 13, 2010
- June 29, 2010
